June 20th 2023 10:00 am ET
Unleashing the Power of Single-Cell RNA-sequencing
Loading...
Explore the Applications of Single-Cell RNA-seq in Drug Discovery
Single-cell RNA-seq (scRNA-seq) analysis is an increasingly important tool for pharmaceutical companies, providing insights for preclinical and clinical studies. This webinar will explore the applications of scRNA-seq in pharmaceutical research, explaining the biological insights that can be obtained from a scRNA-seq analysis.
Through the analysis of scRNA-seq data, pharmaceutical companies can address a variety of questions, such as patient stratification, understanding cell-cell interactions, assessing heterogeneity, and investigating mechanisms of action and drug combinations.
In this webinar, we will discuss the potential of scRNA-seq analysis in the context of pharmaceutical research. We will also touch on emerging techniques such as CITE-seq, Spatial transcriptomics, scRNA-seq + ATAC-seq, and TCR repertoire, and discuss how they can be used to further advance pharmaceutical research.
Through the analysis of scRNA-seq data, pharmaceutical companies can address a variety of questions, such as patient stratification, understanding cell-cell interactions, assessing heterogeneity, and investigating mechanisms of action and drug combinations.
In this webinar, we will discuss the potential of scRNA-seq analysis in the context of pharmaceutical research. We will also touch on emerging techniques such as CITE-seq, Spatial transcriptomics, scRNA-seq + ATAC-seq, and TCR repertoire, and discuss how they can be used to further advance pharmaceutical research.
This webinar will answer questions such as:
-
How can scRNA-seq analysis be used to assess cell heterogeneity in preclinical and clinical studies?
-
What insights can be gained from scRNA-seq analysis to understand the mechanism of action of drugs or drug combinations?
-
How does scRNA-seq analysis help in understanding cell-cell interaction in the context of pharmaceutical research?
-
What are some of the novel techniques that are emerging in the field of scRNA-seq analysis?
Our talented speakers cover research, innovation and intellectual property
Michael Ward
Global Head of Life Sciences and Healthcare Thought Leadership, Clarivate
As both a journalist and analyst, Mike has been writing, analyzing and commenting on
the life sciences industry for more than 35 years. His actionable insights and analysis
support pharma, biotech, healthcare and medtech stakeholders gain a deeper
understanding of market news and trends. Mike has held editorial and content
leadership roles at various publications and organizations across the industry.
Octavio Morante-Palacios
Consultant, Bioinformatics,
Clarivate
Clarivate
During his PhD in Biomedicine, Octavio focused on inflammation, epigenomics, transcriptional regulation, and the development of bioinformatics tools. As a bioinformatics consultant at Clarivate, he has provided valuable insights to pharmaceutical companies through the analysis of single-cell RNA-seq data in oncology, improving the understanding of the mechanisms of action of different drugs.
Ester Gil
Consultant, Bioinformatics, Clarivate
Over her years as an academic, Ester developed expertise in Statistics & Bioinformatics, as well as a deep understanding of Oncology and Immunology. As a bioinformatics consultant, her insights and analytical expertise support pharma companies throughout pre-clinical and clinical stages of the drug development life cycle.
Register below and we'll send the details straight to your inbox.
